A New Treatment for Severe Alopecia Areata Has Been Approved in the USA!
Learn about a new alopecia treatment in the US.
The Burden of Disease in Alopecia Areata: Canadian Online Survey of Patients and Caregivers
The results of the first Canadian study on the burden of disease in Alopecia Areata are now published! This research reveals the psychosocial and financial impacts of alopecia areata on patients and caregivers. Link to the full article is within.
Concert Pharmaceuticals CTP‑543: Is a second FDA-approved treatment for alopecia areata on its way?
Concert Pharmaceuticals reports more positive topline results for CTP-543 as they prepare to submit for FDA approval in the first half of 2023. How exciting!